SEARCH RESULT

Total Matching Records found : 1124

Bt cotton price cut seen as big positive for drought-hit Maharashtra -Abhiram Ghadyalpatil

-Livemint.com The Union government has cut the prices of genetically-modified cotton seeds and slashed royalty fees by 74% The Union government’s decision to cut the prices of genetically-modified (GM) cotton seeds, popularly known as Bt cotton, and slash royalty fees, will have a positive impact on cotton farming in Maharashtra, India’s top state in terms of area under cotton cultivation. The Maharashtra government’s agriculture officials, cotton growers and officials at the Nagpur-based...

More »

The Aadhaar coup -Jean Drèze

-The Hindu The Aadhaar Bill opens the door to mass surveillance. This danger needs to be seen in the light of recent attacks on the right to dissent. No other country, and certainly no democratic country, has ever held its own citizens hostage to such a powerful infrastructure of surveillance. The Aadhaar project was sold to the public based on the claim that enrolment was “voluntary”. This basically meant that there was...

More »

Patents over patients -Shamnad Basheer

-The Indian Express Government privileges the private over the public, preferring trade to health In a dramatic development, US industry groups recently claimed the Indian government offered them a “private” assurance that compulsory licences will not be issued, save in emergencies and for non-commercial purposes. Needless to state, such an assurance flies in the face of the Patents Act and the public health safeguards enshrined in it. Illustratively, Section 84 mandates that...

More »

India Assures the US It Will Not Issue Compulsory Licences on Medicines -Amit Sengupta

-TheWire.in The government appears bent on decisively abandoning the earlier consensus of adherence to public health goals. In what is widely being hailed as an extraordinary victory for the multinational pharmaceutical industry over the Indian government, the US-India Business Council (USIBC), in its submission to the United States Trade Representative (USTR), reports that the Indian government has “privately assured” the industry that it would not use compulsory licences (CLs) for commercial purposes....

More »

Why should we not revoke Bollgard II patent, Centre asks Mahyco Monsanto -KV Kurmanath

-The Hindu Business Line Govt acts on a letter from farmers’ union on bollworm developing resistance to technology   Hyderabad: Even as it announced a nation-wide uniform price for cottonseed for the upcoming kharif season, the Union government has asked Mahyco Monsanto Biotech (India) Limited why it should not revoke the patent it granted for the Bollgard II technology. The Department of Industry Policy and Promotion (DIPP) has served a show cause notice to...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close